[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Europe Meropenem Market Research Report Forecast 2017-2021

March 2017 | 137 pages | ID: E9137BCF6B7EN
S&P Consulting

US$ 3,040.00 US$ 3,800.00 -20 %

E-mail Delivery (PDF), E-mail Delivery (Word), E-mail Delivery (Excel), E-mail Delivery (PowerPoint)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Europe Meropenem Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Meropenem industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Meropenem market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs
Europe Meropenem Market Analysis by Countries:
  • Germany
  • France
  • UK
  • Russia
  • Italy
  • Spain
  • Benelux
The Major players reported in the market include:
Pfizer
Shenzhen Haibin Pharmaceutical
Novartis
Mylan
GE Healthcare
Spectrum Chemical Manufacturing Corp
Abbott
Takeda
Hisun-Pfizer Pharmaceuticals
Europe Meropenem Market Analysis by Product:
Injection
Freeze-dried powder
Type 3
Europe Meropenem Market Analysis by Application:
Hospital use
Clinic
Others

REASONS FOR BUYING THIS REPORT
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
Europe Meropenem Sales Market Report Forecast 2017-2021

1 MEROPENEM MARKET OVERVIEW

1.1 Product Overview and Scope of Meropenem
1.2 Classification of Meropenem
  1.2.1 Injection
  1.2.2 Freeze-dried powder
  1.2.3 Type
1.3 Application of Meropenem
  1.3.2 Hospital use
  1.3.3 Clinic
  1.3.4 Others
1.4 Meropenem Market States Status and Prospect (2012-2021) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Meropenem (2012-2021)
  1.5.1 Europe Meropenem Sales and Growth Rate (2012-2021)
  1.5.2 Europe Meropenem Revenue and Growth Rate (2012-2021)

2 EUROPE ECONOMIC IMPACT ON MEROPENEM INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 MEROPENEM MANUFACTURING COST ANALYSIS

3.1 Meropenem Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Meropenem

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Meropenem Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Meropenem Major Manufacturers in 2015
4.4 Downstream Buyers

5 EUROPE MEROPENEM MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Meropenem Market Competition by Manufacturers
  5.1.1 Europe Meropenem Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Meropenem Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Meropenem (Volume and Value) by Type
  5.2.1 Europe Meropenem Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Meropenem Revenue and Market Share by Type (2012-2017)
5.3 Europe Meropenem (Volume and Value) by Countries
  5.3.1 Europe Meropenem Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Meropenem Revenue and Market Share by Countries (2012-2017)
5.4 Europe Meropenem (Volume) by Application

6 GERMANY MEROPENEM (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Meropenem Sales and Value (2012-2017)
  6.1.1 Germany Meropenem Sales and Growth Rate (2012-2017)
  6.1.2 Germany Meropenem Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Meropenem Sales Price Trend (2012-2017)
6.2 Germany Meropenem Sales and Market Share by Manufacturers
6.3 Germany Meropenem Sales and Market Share by Type
6.4 Germany Meropenem Sales and Market Share by Application

7 FRANCE MEROPENEM (VOLUME, VALUE AND SALES PRICE)

7.1 France Meropenem Sales and Value (2012-2017)
  7.1.1 France Meropenem Sales and Growth Rate (2012-2017)
  7.1.2 France Meropenem Revenue and Growth Rate (2012-2017)
  7.1.3 France Meropenem Sales Price Trend (2012-2017)
7.2 France Meropenem Sales and Market Share by Manufacturers
7.3 France Meropenem Sales and Market Share by Type
7.4 France Meropenem Sales and Market Share by Application

8 UK MEROPENEM (VOLUME, VALUE AND SALES PRICE)

8.1 UK Meropenem Sales and Value (2012-2017)
  8.1.1 UK Meropenem Sales and Growth Rate (2012-2017)
  8.1.2 UK Meropenem Revenue and Growth Rate (2012-2017)
  8.1.3 UK Meropenem Sales Price Trend (2012-2017)
8.2 UK Meropenem Sales and Market Share by Manufacturers
8.3 UK Meropenem Sales and Market Share by Type
8.4 UK Meropenem Sales and Market Share by Application

9 RUSSIA MEROPENEM (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Meropenem Sales and Value (2012-2017)
  9.1.1 Russia Meropenem Sales and Growth Rate (2012-2017)
  9.1.2 Russia Meropenem Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Meropenem Sales Price Trend (2012-2017)
9.2 Russia Meropenem Sales and Market Share by Manufacturers
9.3 Russia Meropenem Sales and Market Share by Type
9.4 Russia Meropenem Sales and Market Share by Application

10 ITALY MEROPENEM (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Meropenem Sales and Value (2012-2017)
  10.1.1 Italy Meropenem Sales and Growth Rate (2012-2017)
  10.1.2 Italy Meropenem Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Meropenem Sales Price Trend (2012-2017)
10.2 Italy Meropenem Sales and Market Share by Manufacturers
10.3 Italy Meropenem Sales and Market Share by Type
10.4 Italy Meropenem Sales and Market Share by Application

11 SPAIN MEROPENEM (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Meropenem Sales and Value (2012-2017)
  11.1.1 Spain Meropenem Sales and Growth Rate (2012-2017)
  11.1.2 Spain Meropenem Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Meropenem Sales Price Trend (2012-2017)
11.2 Spain Meropenem Sales and Market Share by Manufacturers
11.3 Spain Meropenem Sales and Market Share by Type
11.4 Spain Meropenem Sales and Market Share by Application

12 BENELUX MEROPENEM (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Meropenem Sales and Value (2012-2017)
  12.1.1 Benelux Meropenem Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Meropenem Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Meropenem Sales Price Trend (2012-2017)
12.2 Benelux Meropenem Sales and Market Share by Manufacturers
12.3 Benelux Meropenem Sales and Market Share by Type
12.4 Benelux Meropenem Sales and Market Share by Application

13 EUROPE MEROPENEM MANUFACTURERS ANALYSIS

13.1 Pfizer
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Shenzhen Haibin Pharmaceutical
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Novartis
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Mylan
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 GE Healthcare
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 Spectrum Chemical Manufacturing Corp
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Abbott
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Takeda
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 Hisun-Pfizer Pharmaceuticals
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE MEROPENEM MARKET FORECAST (2017-2021)

15.1 Germany Market Forecast (2017-2021)
15.2 France Market Forecast (2017-2021)
15.3 UK Market Forecast (2017-2021)
15.4 Russia Market Forecast (2017-2021)
15.5 Italy Market Forecast (2017-2021)
15.6 Spain Market Forecast (2017-2021)
15.7 Benelux Market Forecast (2017-2021)
15.8 Europe Meropenem Market Forecast by Type (2017-2021)
15.9 Europe Meropenem Market Forecast by Application (2017-2021)

16 APPENDIX
LIST OF TABLES AND FIGURES

Figure Picture of Meropenem
Table Classification of Meropenem
Figure Europe Sales Market Share of Meropenem by Type in 2015
Table Application of Meropenem
Figure Europe Sales Market Share of Meropenem by Application in 2015
Figure Germany Meropenem Revenue and Growth Rate (2012-2021)
Figure France Meropenem Revenue and Growth Rate (2012-2021)
Figure UK Meropenem Revenue and Growth Rate (2012-2021)
Figure Russia Meropenem Revenue and Growth Rate (2012-2021)
Figure Italy Meropenem Revenue and Growth Rate (2012-2021)
Figure Spain Meropenem Revenue and Growth Rate (2012-2021)
Figure Benelux Meropenem Revenue and Growth Rate (2012-2021)
Figure Europe Meropenem Sales and Growth Rate (2012-2021)
Figure Europe Meropenem Revenue and Growth Rate (2012-2021)
Table Europe Meropenem Sales of Key Manufacturers (2015 and 2016)
Table Europe Meropenem Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Meropenem Sales Share by Manufacturers
Figure 2016 Meropenem Sales Share by Manufacturers
Table Europe Meropenem Revenue by Manufacturers (2015 and 2016)
Table Europe Meropenem Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Meropenem Revenue Share by Manufacturers
Table 2016 Europe Meropenem Revenue Share by Manufacturers
Table Europe Meropenem Sales and Market Share by Type (2012-2017)
Table Europe Meropenem Sales Share by Type (2012-2017)
Figure Sales Market Share of Meropenem by Type (2012-2017)
Figure Europe Meropenem Sales Growth Rate by Type (2012-2017)
Table Europe Meropenem Revenue and Market Share by Type (2012-2017)
Table Europe Meropenem Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Meropenem by Type (2012-2017)
Figure Europe Meropenem Revenue Growth Rate by Type (2012-2017)
Table Europe Meropenem Sales and Market Share by Countries (2012-2017)
Table Europe Meropenem Sales Share by Countries (2012-2017)
Figure Sales Market Share of Meropenem by Countries (2012-2017)
Table Europe Meropenem Revenue and Market Share by Countries (2012-2017)
Table Europe Meropenem Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Meropenem by Countries (2012-2017)
Table Europe Meropenem Sales and Market Share by Application (2012-2017)
Table Europe Meropenem Sales Share by Application (2012-2017)
Figure Sales Market Share of Meropenem by Application (2012-2017)
Figure Germany Meropenem Sales and Growth Rate (2012-2017)
Figure Germany Meropenem Revenue and Growth Rate (2012-2017)
Figure Germany Meropenem Sales Price Trend (2012-2017)
Table Germany Meropenem Sales by Manufacturers (2015 and 2016)
Table Germany Meropenem Market Share by Manufacturers (2015 and 2016)
Table Germany Meropenem Sales by Type (2015 and 2016)
Table Germany Meropenem Market Share by Type (2015 and 2016)
Table Germany Meropenem Sales by Application (2015 and 2016)
Table Germany Meropenem Market Share by Application (2015 and 2016)
Figure France Meropenem Sales and Growth Rate (2012-2017)
Figure France Meropenem Revenue and Growth Rate (2012-2017)
Figure France Meropenem Sales Price Trend (2012-2017)
Table France Meropenem Sales by Manufacturers (2015 and 2016)
Table France Meropenem Market Share by Manufacturers (2015 and 2016)
Table France Meropenem Sales by Type (2015 and 2016)
Table France Meropenem Market Share by Type (2015 and 2016)
Table France Meropenem Sales by Application (2015 and 2016)
Table France Meropenem Market Share by Application (2015 and 2016)
Figure UK Meropenem Sales and Growth Rate (2012-2017)
Figure UK Meropenem Revenue and Growth Rate (2012-2017)
Figure UK Meropenem Sales Price Trend (2012-2017)
Table UK Meropenem Sales by Manufacturers (2015 and 2016)
Table UK Meropenem Market Share by Manufacturers (2015 and 2016)
Table UK Meropenem Sales by Type (2015 and 2016)
Table UK Meropenem Market Share by Type (2015 and 2016)
Table UK Meropenem Sales by Application (2015 and 2016)
Table UK Meropenem Market Share by Application (2015 and 2016)
Figure Russia Meropenem Sales and Growth Rate (2012-2017)
Figure Russia Meropenem Revenue and Growth Rate (2012-2017)
Figure Russia Meropenem Sales Price Trend (2012-2017)
Table Russia Meropenem Sales by Manufacturers (2015 and 2016)
Table Russia Meropenem Market Share by Manufacturers (2015 and 2016)
Table Russia Meropenem Sales by Type (2015 and 2016)
Table Russia Meropenem Market Share by Type (2015 and 2016)
Table Russia Meropenem Sales by Application (2015 and 2016)
Table Russia Meropenem Market Share by Application (2015 and 2016)
Figure Italy Meropenem Sales and Growth Rate (2012-2017)
Figure Italy Meropenem Revenue and Growth Rate (2012-2017)
Figure Italy Meropenem Sales Price Trend (2012-2017)
Table Italy Meropenem Sales by Manufacturers (2015 and 2016)
Table Italy Meropenem Market Share by Manufacturers (2015 and 2016)
Table Italy Meropenem Sales by Type (2015 and 2016)
Table Italy Meropenem Market Share by Type (2015 and 2016)
Table Italy Meropenem Sales by Application (2015 and 2016)
Table Italy Meropenem Market Share by Application (2015 and 2016)
Figure Spain Meropenem Sales and Growth Rate (2012-2017)
Figure Spain Meropenem Revenue and Growth Rate (2012-2017)
Figure Spain Meropenem Sales Price Trend (2012-2017)
Table Spain Meropenem Sales by Manufacturers (2015 and 2016)
Table Spain Meropenem Market Share by Manufacturers (2015 and 2016)
Table Spain Meropenem Sales by Type (2015 and 2016)
Table Spain Meropenem Market Share by Type (2015 and 2016)
Table Spain Meropenem Sales by Application (2015 and 2016)
Table Spain Meropenem Market Share by Application (2015 and 2016)
Figure Benelux Meropenem Sales and Growth Rate (2012-2017)
Figure Benelux Meropenem Revenue and Growth Rate (2012-2017)
Figure Benelux Meropenem Sales Price Trend (2012-2017)
Table Benelux Meropenem Sales by Manufacturers (2015 and 2016)
Table Benelux Meropenem Market Share by Manufacturers (2015 and 2016)
Table Benelux Meropenem Sales by Type (2015 and 2016)
Table Benelux Meropenem Market Share by Type (2015 and 2016)
Table Benelux Meropenem Sales by Application (2015 and 2016)
Table Benelux Meropenem Market Share by Application (2015 and 2016)
Table Pfizer Basic Information List
Table Pfizer Meropenem Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Meropenem Sales Market Share (2012-2017)
Table Shenzhen Haibin Pharmaceutical Basic Information List
Table Shenzhen Haibin Pharmaceutical Meropenem Sales, Revenue, Price and Gross Margin (2012-2017)
Table Shenzhen Haibin Pharmaceutical Meropenem Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Meropenem Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Meropenem Sales Market Share (2012-2017)
Table Mylan Basic Information List
Table Mylan Meropenem Sales, Revenue, Price and Gross Margin (2012-2017)
Table Mylan Meropenem Sales Market Share (2012-2017)
Table GE Healthcare Basic Information List
Table GE Healthcare Meropenem Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GE Healthcare Meropenem Sales Market Share (2012-2017)
Table Spectrum Chemical Manufacturing Corp Basic Information List
Table Spectrum Chemical Manufacturing Corp Meropenem Sales, Revenue, Price and Gross Margin (2012-2017)
Table Spectrum Chemical Manufacturing Corp Meropenem Sales Market Share (2012-2017)
Table Abbott Basic Information List
Table Abbott Meropenem Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Abbott Meropenem Sales Market Share (2012-2017)
Table Takeda Basic Information List
Table Takeda Meropenem Sales, Revenue, Price and Gross Margin (2012-2017)
Table Takeda Meropenem Sales Market Share (2012-2017)
Table Hisun-Pfizer Pharmaceuticals Basic Information List
Table Hisun-Pfizer Pharmaceuticals Meropenem Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hisun-Pfizer Pharmaceuticals Meropenem Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Meropenem
Figure Manufacturing Process Analysis of Meropenem
Figure Meropenem Industrial Chain Analysis
Table Raw Materials Sources of Meropenem Major Manufacturers in 2015
Table Major Buyers of Meropenem
Table Distributors/Traders List
Figure Germany Meropenem Sales and Growth Rate Forecast (2017-2021)
Figure Germany Meropenem Revenue and Growth Rate Forecast (2017-2021)
Figure France Meropenem Sales and Growth Rate Forecast (2017-2021)
Figure France Meropenem Revenue and Growth Rate Forecast (2017-2021)
Figure UK Meropenem Sales and Growth Rate Forecast (2017-2021)
Figure UK Meropenem Revenue and Growth Rate Forecast (2017-2021)
Figure Russia Meropenem Sales and Growth Rate Forecast (2017-2021)
Figure Russia Meropenem Revenue and Growth Rate Forecast (2017-2021)
Figure Italy Meropenem Sales and Growth Rate Forecast (2017-2021)
Figure Italy Meropenem Revenue and Growth Rate Forecast (2017-2021)
Figure Spain Meropenem Sales and Growth Rate Forecast (2017-2021)
Figure Spain Meropenem Revenue and Growth Rate Forecast (2017-2021)
Figure Benelux Meropenem Sales and Growth Rate Forecast (2017-2021)
Figure Benelux Meropenem Revenue and Growth Rate Forecast (2017-2021)
Table Europe Meropenem Sales Forecast by Type (2017-2021)
Table Europe Meropenem Sales Forecast by Application (2017-2021)


More Publications